Cellmid, Fujikura Kasei Co. Ltd. deal

Fujikura received an option to license use of Cellmid's midkine ( MDK; MK) diagnostic antibodies on Fujikura's latex-based assay technology. Cellmid will receive an upfront fee and is eligible for an...